These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6164407

  • 1. Management of depression with serotonin precursors.
    van Praag HM.
    Biol Psychiatry; 1981 Mar; 16(3):291-310. PubMed ID: 6164407
    [Abstract] [Full Text] [Related]

  • 2. Serotonin precursors in the treatment of depression.
    van Praag HM.
    Adv Biochem Psychopharmacol; 1982 Mar; 34():259-86. PubMed ID: 6753514
    [Abstract] [Full Text] [Related]

  • 3. [Serotonin precursors as antidepressive agents: a review].
    Beckmann H, Kasper S.
    Fortschr Neurol Psychiatr; 1983 May; 51(5):176-82. PubMed ID: 6603403
    [Abstract] [Full Text] [Related]

  • 4. The Harold E. Himwich Memorial Lecture. Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders.
    Praag HM.
    Biol Psychiatry; 1977 Feb; 12(1):101-31. PubMed ID: 300032
    [Abstract] [Full Text] [Related]

  • 5. Chemoprophylaxis of depressions. An attempt to compare lithium with 5-hydroxytryptophan.
    van Praag HM, de Haan S.
    Acta Psychiatr Scand Suppl; 1981 Feb; 290():191-201. PubMed ID: 6164250
    [Abstract] [Full Text] [Related]

  • 6. Remarks on the therapy of depressions with amine precursors.
    Hippius H, Matussek N.
    Psychopathology; 1986 Feb; 19 Suppl 2():132-5. PubMed ID: 3495015
    [Abstract] [Full Text] [Related]

  • 7. 5-Hydroxytryptophan: a clinically-effective serotonin precursor.
    Birdsall TC.
    Altern Med Rev; 1998 Aug; 3(4):271-80. PubMed ID: 9727088
    [Abstract] [Full Text] [Related]

  • 8. Depression vulnerability and 5-hydroxytryptophan prophylaxis.
    van Praag H, de Hann S.
    Psychiatry Res; 1980 Sep; 3(1):75-83. PubMed ID: 6160599
    [Abstract] [Full Text] [Related]

  • 9. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
    Byerley WF, Risch SC.
    J Clin Psychopharmacol; 1985 Aug; 5(4):191-206. PubMed ID: 2410463
    [Abstract] [Full Text] [Related]

  • 10. Use of neurotransmitter precursors for treatment of depression.
    Meyers S.
    Altern Med Rev; 2000 Feb; 5(1):64-71. PubMed ID: 10696120
    [Abstract] [Full Text] [Related]

  • 11. The indoleamine hypothesis of depression: an overview and pilot study.
    Zarcone VP, Berger PA, Brodie KH, Sack R, Barchas JD.
    Dis Nerv Syst; 1977 Aug; 38(8):646-53. PubMed ID: 328245
    [Abstract] [Full Text] [Related]

  • 12. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin.
    van Praag HM, Korf J, Lequin RM.
    Psychopharmacol Commun; 1976 Aug; 2(5-6):369-78. PubMed ID: 1088302
    [Abstract] [Full Text] [Related]

  • 13. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.
    Turner EH, Loftis JM, Blackwell AD.
    Pharmacol Ther; 2006 Mar; 109(3):325-38. PubMed ID: 16023217
    [Abstract] [Full Text] [Related]

  • 14. [Serotoninergic depression--hypothesis or reality?].
    Leboyer M, Plaisant O.
    Encephale; 1983 Mar; 9(4):317-30. PubMed ID: 6200312
    [Abstract] [Full Text] [Related]

  • 15. [Indoleamine precursors in depression (author's transl)].
    Coppen A, Wood K.
    Encephale; 1979 Mar; 5(5 Suppl):627-32. PubMed ID: 95009
    [Abstract] [Full Text] [Related]

  • 16. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
    Takahashi S, Takahashi R, Masumura I, Miike A.
    Folia Psychiatr Neurol Jpn; 1976 Mar; 30(4):461-73. PubMed ID: 1087913
    [Abstract] [Full Text] [Related]

  • 17. Neurotransmitter precursors for the treatment of depression.
    Gelenberg AJ, Gibson CJ, Wojcik JD.
    Psychopharmacol Bull; 1982 Jan; 18(1):7-18. PubMed ID: 6124021
    [No Abstract] [Full Text] [Related]

  • 18. Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls.
    Croonenberghs J, Verkerk R, Scharpe S, Deboutte D, Maes M.
    Life Sci; 2005 Mar 25; 76(19):2171-83. PubMed ID: 15733932
    [Abstract] [Full Text] [Related]

  • 19. The relationship of serotonin to depression in Parkinson's disease.
    Mayeux R, Stern Y, Sano M, Williams JB, Cote LJ.
    Mov Disord; 1988 Mar 25; 3(3):237-44. PubMed ID: 2461509
    [Abstract] [Full Text] [Related]

  • 20. Central monoamine metabolism in depressions. I. Serotonin and related compounds.
    van Praag HM.
    Compr Psychiatry; 1980 Mar 25; 21(1):30-43. PubMed ID: 6153593
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.